Literature DB >> 11517957

Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally.

P Gunczler1, R Lanes, V Paz-Martinez, R Martins, S Esaa, V Colmenares, J R Weisinger.   

Abstract

The effects of insulin dependent diabetes mellitus (IDDM) on bone metabolism are still not well defined. We evaluated total bone mineral content (TBMC) and bone mineral density (BMD) at the lumbar spine and femoral neck using dual X-ray absorptiometry in 26 IDDM children (15 M, 11 F) with a mean chronological age of 12.1+/-3.1 yr (range 7.1-14.2 yr). Duration of diabetes was 4.3+/-2.9 yr, with a mean glycosylated hemoglobin of 9.2+/-0.4%. BMD and TBMC standard deviation scores (Z-scores) were determined by comparing our results to controls matched for age, sex and pubertal status. BMD and bone formation and resorption markers were determined at the beginning of the study and after one year of follow up. Mean lumbar spine Z-score was -1.06+/-0.2, with negative values in 24 of 26 children (92.6%); 14/26 patients (53.8%) had a lumbar spine Z-score >1.0 SD below the mean. Mean lumbar spine Z-score remained unchanged after one year of follow up (-1.02+/-0.3). No significant differences were obtained in femoral neck BMD or TBMC between groups. No correlation was observed between lumbar spine BMD Z-scores and duration of IDDM or degree of diabetes control, as assessed by the mean glycosylated hemoglobin. Daily urinary calcium excretion was elevated in our patients initially and after one year of follow up; however, no correlation was obtained between lumbar spine BMD and 24 h urinary calcium excretion. Carboxy-terminal propeptide of type 1 collagen values and levels of urinary cross-linked N-telopeptides of type 1 collagen in the diabetic children were significantly lower than those of the matched controls. Osteoblastic activity as assessed by serum osteocalcin and by the carboxy-terminal propeptide of type I collagen and bone resorption as measured by cross-linked N-telopeptides of type 1 collagen did not correlate with the lumbar spine Z-scores. When IDDM patients were subdivided into males and females and into children with more than or less than 2 yr duration of diabetes since diagnosis, no differences between groups were found. These results suggest that insulin dependent diabetes in children is associated with low bone turnover resulting in a deficit in bone mass which may be manifested as osteopenia in the growing bone. This defect is already present in trabecular bone early on in the disease and seems not to be related to glycemic control.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 11517957     DOI: 10.1515/jpem.1998.11.3.413

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  40 in total

Review 1.  Osteoporosis and diabetes mellitus.

Authors:  Angela M Inzerillo; Solomon Epstein
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

2.  Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes.

Authors:  Ernesto Maddaloni; Luca D'Onofrio; Angelo Lauria; Anna Rita Maurizi; Rocky Strollo; Andrea Palermo; Nicola Napoli; Silvia Angeletti; Paolo Pozzilli; Silvia Manfrini
Journal:  J Endocrinol Invest       Date:  2014-05-24       Impact factor: 4.256

3.  Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.

Authors:  B A Perry; K R Archer; Y Song; Y Ma; J K Green; F Elefteriou; K M Dahir
Journal:  Osteoporos Int       Date:  2016-02-29       Impact factor: 4.507

Review 4.  Bone, sweet bone--osteoporotic fractures in diabetes mellitus.

Authors:  Christine Hamann; Stephan Kirschner; Klaus-Peter Günther; Lorenz C Hofbauer
Journal:  Nat Rev Endocrinol       Date:  2012-01-17       Impact factor: 43.330

5.  Bone cells and bone turnover in diabetes mellitus.

Authors:  Mishaela R Rubin
Journal:  Curr Osteoporos Rep       Date:  2015-06       Impact factor: 5.096

Review 6.  Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.

Authors:  Kathryn M Thrailkill; Charles K Lumpkin; R Clay Bunn; Stephen F Kemp; John L Fowlkes
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11       Impact factor: 4.310

7.  Poor Glycemic Control Is Associated With Impaired Bone Accrual in the Year Following a Diagnosis of Type 1 Diabetes.

Authors:  David R Weber; Rebecca J Gordon; Jennifer C Kelley; Mary B Leonard; Steven M Willi; Jacquelyn Hatch-Stein; Andrea Kelly; Oksana Kosacci; Olena Kucheruk; Mirna Kaafarani; Babette S Zemel
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

Review 8.  A new perspective on mechanisms governing skeletal complications in type 1 diabetes.

Authors:  Zeynep Seref-Ferlengez; Sylvia O Suadicani; Mia M Thi
Journal:  Ann N Y Acad Sci       Date:  2016-08-29       Impact factor: 5.691

9.  Celiac disease and pediatric type 1 diabetes: diagnostic and treatment dilemmas.

Authors:  Shama Sud; Margaret Marcon; Esther Assor; Mark R Palmert; Denis Daneman; Farid H Mahmud
Journal:  Int J Pediatr Endocrinol       Date:  2010-06-23

Review 10.  Diabetes mellitus and osteoporosis.

Authors:  Robert Sealand; Christie Razavi; Robert A Adler
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.